Search research articles
Contact Us
Filters
Showing results (61-70 of 113) with videos related to
Page
of 12
Sort By:
Atherosclerosis
|
December 20, 2017
Genetic variants in PPARGC1B and CNTN4 are associated with thromboxane A<sub>2</sub> formation and with cardiovascular event free survival in the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT)
Nina S McCarthy, Ciara Vangjeli, Praveen Surendran, et al.
Journal of the American Heart Association
|
May 4, 2017
Risk for Incident Heart Failure: A Subject-Level Meta-Analysis From the Heart "OMics" in AGEing (HOMAGE) Study
Lotte Jacobs, Ljupcho Efremov, João Pedro Ferreira, et al.
Journal of the American College of Cardiology
|
September 17, 2021
Side Effect Patterns in a Crossover Trial of Statin, Placebo, and No Treatment
James P Howard, Frances A Wood, Judith A Finegold, et al.
The New England Journal of Medicine
|
November 16, 2020
N-of-1 Trial of a Statin, Placebo, or No Treatment to Assess Side Effects
Frances A Wood, James P Howard, Judith A Finegold, et al.
European Journal of Heart Failure
|
April 2, 2022
Comparing and contrasting risk factors for heart failure in patients with and without history of myocardial infarction: data from HOMAGE and the UK Biobank
Tripti Rastogi, Frederick K Ho, Patrick Rossignol, et al.
Journal of Biomedical Research
|
October 22, 2014
Heart 'omics' in AGEing (HOMAGE): design, research objectives and characteristics of the common database
Lotte Jacobs, Lutgarde Thijs, Yu Jin, et al.
Lancet (London, England)
|
September 13, 2016
Interpretation of the evidence for the efficacy and safety of statin therapy
Rory Collins, Christina Reith, Jonathan Emberson, et al.
Journal of Lipid Research
|
February 28, 2012
Genome-wide association study of genetic determinants of LDL-c response to atorvastatin therapy: importance of Lp(a)
Harshal A Deshmukh, Helen M Colhoun, Toby Johnson, et al.
Circulation. Heart Failure
|
May 16, 2023
Protein Biomarkers of New-Onset Heart Failure: Insights From the Heart Omics and Ageing Cohort, the Atherosclerosis Risk in Communities Study, and the Framingham Heart Study
Nicolas Girerd, Daniel Levy, Kevin Duarte, et al.
Circulation. Heart Failure
|
May 21, 2019
Proteomic Bioprofiles and Mechanistic Pathways of Progression to Heart Failure
João Pedro Ferreira, Job Verdonschot, Timothy Collier, et al.
Page
of 12
Search research articles
Search
Showing results (61-70 of 113) with videos related to
Sort By:
Page
of 12
Atherosclerosis
|
December 20, 2017
Genetic variants in PPARGC1B and CNTN4 are associated with thromboxane A<sub>2</sub> formation and with cardiovascular event free survival in the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT)
Nina S McCarthy, Ciara Vangjeli, Praveen Surendran, et al.
Journal of the American Heart Association
|
May 4, 2017
Risk for Incident Heart Failure: A Subject-Level Meta-Analysis From the Heart "OMics" in AGEing (HOMAGE) Study
Lotte Jacobs, Ljupcho Efremov, João Pedro Ferreira, et al.
Journal of the American College of Cardiology
|
September 17, 2021
Side Effect Patterns in a Crossover Trial of Statin, Placebo, and No Treatment
James P Howard, Frances A Wood, Judith A Finegold, et al.
The New England Journal of Medicine
|
November 16, 2020
N-of-1 Trial of a Statin, Placebo, or No Treatment to Assess Side Effects
Frances A Wood, James P Howard, Judith A Finegold, et al.
European Journal of Heart Failure
|
April 2, 2022
Comparing and contrasting risk factors for heart failure in patients with and without history of myocardial infarction: data from HOMAGE and the UK Biobank
Tripti Rastogi, Frederick K Ho, Patrick Rossignol, et al.
Journal of Biomedical Research
|
October 22, 2014
Heart 'omics' in AGEing (HOMAGE): design, research objectives and characteristics of the common database
Lotte Jacobs, Lutgarde Thijs, Yu Jin, et al.
Lancet (London, England)
|
September 13, 2016
Interpretation of the evidence for the efficacy and safety of statin therapy
Rory Collins, Christina Reith, Jonathan Emberson, et al.
Journal of Lipid Research
|
February 28, 2012
Genome-wide association study of genetic determinants of LDL-c response to atorvastatin therapy: importance of Lp(a)
Harshal A Deshmukh, Helen M Colhoun, Toby Johnson, et al.
Circulation. Heart Failure
|
May 16, 2023
Protein Biomarkers of New-Onset Heart Failure: Insights From the Heart Omics and Ageing Cohort, the Atherosclerosis Risk in Communities Study, and the Framingham Heart Study
Nicolas Girerd, Daniel Levy, Kevin Duarte, et al.
Circulation. Heart Failure
|
May 21, 2019
Proteomic Bioprofiles and Mechanistic Pathways of Progression to Heart Failure
João Pedro Ferreira, Job Verdonschot, Timothy Collier, et al.
Page
of 12